Reasons to be optimistic about new antibiotic development
Two years ago, the outlook for viable antibiotics looked bleak. Now policymakers have realised the scope of the problem, while a number of new innovations are in the pipeline. Bacteria are clever, says Dr Christopher Burns, President and CEO of Pennsylvania-based pharma company, Venatorx Pharmaceuticals. You can put them under pressure with an antibiotic, but … Continued